| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() FDA Clears Cryosurgical Treatment For Verruca Plana LEHIGH VALLEY, PA -- January 21, 1998 -- STC Technologies, Inc. has received clearance from the FDA to market its Histofreezer(R) Cryosurgical Wart Treatment for verruca plana. Verruca plana is a small, flesh-coloured, flat topped lesion that commonly occurs on the face, neck, and back of hands of children and young adults. Histofreezer is indicated for the treatment of verruca vulgaris (common warts), verruca plantaris (plantar warts), HPV (genital lesions), acrochordon (skin tags), molluscum contagiosum, seborrhoeic keratosis, and now, verruca plana. In the removal of benign skin lesions, Histofreezer has been shown to be an effective and economical alternative to liquid nitrogen. Histofreezer units are available in 5 mm, 40 applicator kits or 2 mm, 50 applicator kits. Each kit contains a CPT code manual, a Material Safety Data Sheet (MSDS) and a complete set of instructions. Histofreezer may be stored at room temperature and has a four-year shelf life from date of manufacture.
|